Sato S - Search Results

1

Autoantibodies against calpastatin in sera from patients with systemic sclerosis.

Sato S, Hasegawa M, Nagaoka T, Takamatsu Y, Yazawa N, Ihn H, Kikuchi K, Takehara K. Sato S, et al. J Rheumatol. 1998 Nov;25(11):2135-9. J Rheumatol. 1998. PMID: 9818655

2

Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.

Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K. Ihn H, et al. Among authors: sato s. Clin Exp Immunol. 2000 Jan;119(1):203-9. doi: 10.1046/j.1365-2249.2000.01115.x. Clin Exp Immunol. 2000. PMID: 10606984 Free PMC article.

3

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K. Sato S, et al. J Rheumatol. 2000 Jan;27(1):149-54. J Rheumatol. 2000. PMID: 10648031

4

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: sato s. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

5

Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.

Sato S, Nagaoka T, Hasegawa M, Nishijima C, Takehara K. Sato S, et al. Dermatology. 2000;200(3):196-201. doi: 10.1159/000018382. Dermatology. 2000. PMID: 10828626

6

Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.

Nagaoka T, Sato S, Hasegawa M, Ihn H, Takehara K. Nagaoka T, et al. Among authors: sato s. J Rheumatol. 2000 Aug;27(8):1917-21. J Rheumatol. 2000. PMID: 10955333

7

Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.

Sato S, Hanakawa H, Hasegawa M, Nagaoka T, Hamaguchi Y, Nishijima C, Komatsu K, Hirata A, Takehara K. Sato S, et al. J Rheumatol. 2000 Dec;27(12):2838-42. J Rheumatol. 2000. PMID: 11128673

8

Elevated serum levels of soluble L-selectin in patients with systemic sclerosis declined after intravenous injection of lipo-prostaglandin E1.

Inaoki M, Sato S, Shimada Y, Takehara K. Inaoki M, et al. Among authors: sato s. J Dermatol Sci. 2001 Jan;25(1):78-82. doi: 10.1016/s0923-1811(00)00108-0. J Dermatol Sci. 2001. PMID: 11154868

9

Renal vascular damage in Japanese patients with systemic sclerosis.

Nishijima C, Sato S, Hasegawa M, Nagaoka T, Hirata A, Komatsu K, Takehara K. Nishijima C, et al. Among authors: sato s. Rheumatology (Oxford). 2001 Apr;40(4):406-9. doi: 10.1093/rheumatology/40.4.406. Rheumatology (Oxford). 2001. PMID: 11312378

10

Elevated serum L-selectin levels and decreased L-selectin expression on CD8(+) lymphocytes in systemic sclerosis.

Shimada Y, Hasegawa M, Takehara K, Sato S. Shimada Y, et al. Among authors: sato s. Clin Exp Immunol. 2001 Jun;124(3):474-9. doi: 10.1046/j.1365-2249.2001.01514.x. Clin Exp Immunol. 2001. PMID: 11472411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,281 results

Search Page

Filters